share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：诺和诺德-股票回购计划
美股sec公告 ·  07/09 09:50
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on May 6, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting February 6, 2024. As of July 5, 2024, the company has repurchased 10,246,595 B shares at an average price of DKK 875.46 per share, totaling DKK 8,970,451,933. The recent transactions from July 1 to July 5, 2024, resulted in the acquisition of 184,970 B shares for DKK 182,081,764. Following these purchases, Novo Nordisk holds 11,612,159 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange. Novo Nordisk is committed to combating serious chronic diseases and employs approximately 66,000 people worldwide.
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on May 6, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting February 6, 2024. As of July 5, 2024, the company has repurchased 10,246,595 B shares at an average price of DKK 875.46 per share, totaling DKK 8,970,451,933. The recent transactions from July 1 to July 5, 2024, resulted in the acquisition of 184,970 B shares for DKK 182,081,764. Following these purchases, Novo Nordisk holds 11,612,159 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange. Novo Nordisk is committed to combating serious chronic diseases and employs approximately 66,000 people worldwide.
全球领先的医疗保健公司诺和诺德（Novo Nordisk A/S）积极执行于2024年5月6日宣布的股份回购计划。该计划是更大的一项计划的一部分，该计划将于2024年2月6日起12个月内回购高达200亿丹麦克朗的股份。截至2024年7月5日，该公司以平均每股875.46丹麦克朗的价格回购了102465950亿股，总计8970451933亿丹麦克朗。2024年7月1日至7月5日的最近交易导致收购了1849700亿股，价格为182081764丹麦克朗。经过这些购买，诺和诺德（Novo Nordisk）持有116121590亿股的库存股，占股本总额的0.3％。该公司的股票在纳斯达克哥本哈根交易，其美国存托凭证在纽约证交所上市。诺和诺德致力于解决严重慢性疾病，全球拥有约66000名员工。
全球领先的医疗保健公司诺和诺德（Novo Nordisk A/S）积极执行于2024年5月6日宣布的股份回购计划。该计划是更大的一项计划的一部分，该计划将于2024年2月6日起12个月内回购高达200亿丹麦克朗的股份。截至2024年7月5日，该公司以平均每股875.46丹麦克朗的价格回购了102465950亿股，总计8970451933亿丹麦克朗。2024年7月1日至7月5日的最近交易导致收购了1849700亿股，价格为182081764丹麦克朗。经过这些购买，诺和诺德（Novo Nordisk）持有116121590亿股的库存股，占股本总额的0.3％。该公司的股票在纳斯达克哥本哈根交易，其美国存托凭证在纽约证交所上市。诺和诺德致力于解决严重慢性疾病，全球拥有约66000名员工。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息